First Report and Comparative Genomics Analysis of a [bla.sub.OXA-244]-Harboring Escherichia coli Isolate Recovered in the American Continent
The carbapenemase OXA-244 is a derivate of OXA-48, and its detection is very difficult in laboratories. Here, we report the identification and genomic analysis of an Escherichia coli isolate (28Eco12) harboring the [bla.sub.OXA-244] gene identified in Colombia, South America. The 28Eco12 isolate was...
Saved in:
Published in | Antibiotics (Basel) Vol. 8; no. 4 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
MDPI AG
01.12.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The carbapenemase OXA-244 is a derivate of OXA-48, and its detection is very difficult in laboratories. Here, we report the identification and genomic analysis of an Escherichia coli isolate (28Eco12) harboring the [bla.sub.OXA-244] gene identified in Colombia, South America. The 28Eco12 isolate was identified during a retrospective study, and it was recovered from a patient treated in Colombia. The complete nucleotide sequence was established using the PacBio platform. A comparative genomics analysis with other [bla.sub.OXA-244]-harboring Escherichia coli strains was performed. The 28Eco12 isolate belonged to sequence type (ST) 38, and its genome was composed of two molecules, a chromosome of 5,343,367 bp and a plasmid of 92,027 bp, which belonged to the incompatibility group IncY and did not harbor resistance genes. The [bla.sub.OXA-244] gene was chromosomally encoded and mobilized by an ISR1-related Tn6237 composite transposon. Notably, this transposon was inserted and located within a new genomic island. To our knowledge, this is the first report of a [bla.sub.OXA-244]-harboring Escherichia coli isolate in America. Our results suggest that the introduction of the OXA-244-producing E. coli isolate was through clonal expansion of the ST38 pandemic clone. Other isolates producing OXA-244 could be circulating silently in America. |
---|---|
ISSN: | 2079-6382 2079-6382 |
DOI: | 10.3390/antibiotics8040222 |